Potential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetes.

Teunis CJ, Collins TJC, Oostveen RF, Neele AE, de Winther M, Nurmohamed NS, Heijmans J, Winkelmeijer M, Dzobo KE, Cooper ME, van Raalte DH, Nieuwdorp M, Verberne HJ, Stroes ESG, Murphy AJ, Kroon J, Hanssen NMJ

Open source

DOI: 10.1093/eurheartj/ehag627
Published: 2026 Sep 29
Container: European heart journal
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehag627,
  title = {Potential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetes.},
  author = {Teunis CJ and Collins TJC and Oostveen RF and Neele AE and de Winther M and Nurmohamed NS and Heijmans J and Winkelmeijer M and Dzobo KE and Cooper ME and van Raalte DH and Nieuwdorp M and Verberne HJ and Stroes ESG and Murphy AJ and Kroon J and Hanssen NMJ},
  year = {2026},
  journal = {European heart journal},
  doi = {10.1093/eurheartj/ehag627},
  url = {https://doi.org/10.1093/eurheartj/ehag627}
}

RIS

TY  - JOUR
TI  - Potential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetes.
AU  - Teunis CJ
AU  - Collins TJC
AU  - Oostveen RF
AU  - Neele AE
AU  - de Winther M
AU  - Nurmohamed NS
AU  - Heijmans J
AU  - Winkelmeijer M
AU  - Dzobo KE
AU  - Cooper ME
AU  - van Raalte DH
AU  - Nieuwdorp M
AU  - Verberne HJ
AU  - Stroes ESG
AU  - Murphy AJ
AU  - Kroon J
AU  - Hanssen NMJ
PY  - 2026
JO  - European heart journal
DO  - 10.1093/eurheartj/ehag627
UR  - https://doi.org/10.1093/eurheartj/ehag627
ER  -

APA

CJ, T., TJC, C., RF, O., AE, N., M, D. W., NS, N., J, H., M, W., KE, D., ME, C., DH, V. R., M, N., HJ, V., ESG, S., AJ, M., J, K., & NMJ, H. (2026). Potential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetes.. European heart journal. https://doi.org/10.1093/eurheartj/ehag627

Source records

pubmed · retrieved 2026-11-10T19:16:41.913Z